GSK plc (LSE: GSK): GSK agrees to buy lung cancer specialist Nuvalent for $10.6bn
09 Jun 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
GSK plc (GSK:LON) | 1,881 -592.6 (-1.6%) | Mkt Cap: 76,165m
- Published:
09 Jun 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
3 -
GSK plc (LSE: GSK): GSK agrees to buy lung cancer specialist Nuvalent for $10.6bn